Battle cancer together with TrueHb

Hemoglobin monitoring is a crucial tool in combating cancer. It provides overall insights into the dynamic aspects of cancer progression and treatment responses.

Monitor Hemoglobin in Cancer

Why do you need to monitor Hemoglobin in Cancer?

Optimal Hemoglobin - TrueHb

Optimal Hemoglobin: A ray of light in cancer fight!

Cancer is a serious and life-threatening condition. When the normal cells of the human body start dividing uncontrollably and become abnormal, the condition is called cancer. The lump of these abnormal cells then forms a tumour which interferes with the functioning of the body. It may or may not spread to other parts of the body.
The symptoms of the cancer depend on the affected part of the body and the patients may suffer weight loss, fatigue, pain, swelling, discomfort, and headaches. Various treatment options have been available that help in fighting cancer such as chemotherapy, radiotherapy, and surgery. In cancer patients and patients undergoing chemotherapy, the production of blood cells decreases due to abnormal functioning of the body. As a result, the hemoglobin levels decrease and cause anemia. Patients with anemia may require iron supplements, erythropoiesis stimulating agents (ESA) therapy, and blood transfusions to increase their hemoglobin levels and improve their overall health and quality of life.
Chemotherapy sessions are based on optimal hemoglobin levels. Cancer patients undergoing chemotherapy suffer anemia due to low hemoglobin levels. The common symptoms in such patients include the following:-
  1. Fatigue
  2. Vomiting
  3. Hair loss
  4. Loss of appetite
  5. Mouth soreness
  6. Diarrhoea or constipation
  7. Brittle nails
  8. Mood swings
  9. Fertility issues, and
  10. Difficulty in concentration
Cancer patients undergoing chemotherapy need to maintain their hemoglobin levels between 10-11g/dL. Before performing chemotherapy, the doctors check the hemoglobin levels of cancer patients and then only perform the treatment, if in range. When the hemoglobin is less than 10 g/dL, the doctors prescribe Erythropoietin stimulating agents (ESA) to increase hemoglobin and treat anemia in cancer patients. If hemoglobin is more than 11g/dL in patients undergoing chemotherapy, it increases the risk of heart attack. Therefore, it is important to monitor hemoglobin levels regularly to battle cancer and to decrease the risk of cancer-related anemia and cardiovascular events. Be a cancer fighter with TrueHb!
Read More
Role of Hemoglobin monitoring in Cancer

Role of Hemoglobin monitoring in Cancer

What TrueHb users have to say

Empower Your Health Journey with TrueHb

TrueHb Hemoglobin Monitoring kit

TrueHb Hemoglobin Monitoring kit

US Patented Technology| Instant Results| Wide range of measurement| Accuracy as per US CLIA guidelines|

  1. Rechargeable Battery
  2. Accuracy as per USFDA CLIA guidelines
  3. Wide Measurement Range 0 – 24g/dl
  4. Operating range 5 – 55°C
  5. Two Years Shelf Life of Strips
  6. 23 Gauge lancets for accurate results

Frequently Asked Questions

1. Do hemoglobin levels fluctuate in cancer?

Yes, hemoglobin levels fluctuate in cancer patients. 

Currently, doctors ask the patients to get their hemoglobin tested in their labs or hospitals. Chemotherapy can only be performed if the hemoglobin of the cancer patient is in the range of 10-12 g/dL. If the patient has low hemoglobin, the patient feels week and scheduled chemotherapy cannot be performed which leads to an inconvenience for the patient. You can monitor your hemoglobin levels with a TrueHb hemoglobin monitoring device at home with one drop under one minute.

Cancer affects the production of red blood cells and patients who are going through chemotherapy develop anemia due to low hemoglobin levels.

Fatigue, weakness, shortness of breath, paleness, and dizziness are the common symptoms of anemia in cancer patients. Findings of the research papers have shown that maintaining the right hemoglobin levels in cancer patients improves their quality of life.

Treatment options include iron supplements, erythropoiesis-stimulating agents (ESAs), and blood transfusions in severe cases.

Yes, ESA usage may increase the risk of blood clot formation and progression of cancer. It is important to check the effects of ESA therapy on cancer patients by monitoring hemoglobin levels. ESA therapy is given to avoid blood transfusion and improve patients’ life by increasing the hemoglobin levels.

It should be monitored regularly, once in a week or fortnightly, as required. Cancer patients should also monitor their hemoglobin levels before going to their chemotherapy sessions to avoid inconvenience.

The cancer patients have to maintain hemoglobin in the range of 10-12 g/dL. Hemoglobin levels below 10 g/dL are considered low hemoglobin, and cause anemia.

Yes, low hemoglobin levels may limit the efficacy of cancer treatments like chemotherapy and radiation therapy.

No, hemoglobin monitoring is also important in long-term follow-up care for cancer survivors due to the risk of cancer recurrence.

No, monitoring your hemoglobin levels with a TrueHb device is not painful. You just need one prick to test your hemoglobin within seconds.

Let us know about your health issues!

Recognizing symptoms is vital for addressing hemoglobin deficiency. If you've noticed any symptoms, please provide your email/phone number to recieve your symptom results for a free consultation with us if you are concerned about your health.